Raul Santos: Why Does LDL-C Remain Elevated in Many Patients?
Raul Santos, Researcher at ARO Hospital Israelita Albert Einstein, shared on LinkedIn about a recent article he and Daniel Added co-authored published in JACC Journals, adding:
“In this editorial published in JACC Asia, Daniel Added and I comment on the results of the study by Puri et al., which evaluated attainment of LDL-C goals in Indian patients.
Unfortunately as seen in other countries most patients remained with still high LDL-C values despite the use of statin therapy in most of them.
Nowadays, it has been shown that more intensive cholesterol lowering to values around 30-40 mg/dL further reduces cardiovascular events in comparison with values around 90 mg/dL.
There is a need for access to additional cholesterol-lowering medications, such as ezetimibe, bempedoic acid, and PCSK9 inhibitors like evolocumab, alirocumab, and inclisiran to adequately control LDL-C and reduce the burden of ASCVD events.
Hopefully, the arrival of oral PCSK9 inhibitors like enlicited and laroprovastat will increase access to these therapies.”
Title: LDL-C Remains Elevated in Patients With Very High Cardiovascular Risk in India and Elsewhere
Authors: Daniel A. Added, Raul D. Santos
Title: Low-Density Lipoprotein Cholesterol Goal Attainment in Indian Patients With Coronary Artery Disease: A Nationwide Study
Authors: Raman Puri, Manish Bansal, Kunal Mahajan, Rajeev Gupta, Vimal Mehta, Shamanna S. Iyengar, Dorairaj Prabhakar, Rajeev Agarwala, Aziz Khan, Neil Bordoloi, Nagaraj Desai, Sheeba George, Biswajit Majumder, Smit Shrivastava, Vinod Vijan, Asha Mahilmaran, Dharmendra Jain, Sadanand R. Shetty, P. Barton Duell, Nathan D. Wong
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia